Colin Fairchild
Colin Fairchild writes for Merja Review and other Independent Journal publications, covering earnings and corporate announcements and M&A, activist stakes and investment banks. Reporting under this byline is prepared by the Independent Journal editorial desk from primary sources, with AI assistance, and reviewed under our editorial policy.
4 articles
Boxlight 8-K Isn't Clearly a Merger 8-K, but Merits a Look
Boxlight's Oct. 6 8-K combines a material agreement, an unregistered equity sale and charter changes. Here is what the item mix signals and what's still unknown.
Proxy fights explained: how contested director elections work
Proxy fights explained: how dissidents nominate directors, the SEC proxy rules, universal proxy notice and filing deadlines, the meeting and how fights end.
Activist Investor Stake: Equinox Partners Files 13D on Silvercrest
Equinox Partners and Sean Fieler reported 554,736 Silvercrest shares, about 7.1%, on Schedule 13D and left room to push on capital allocation or a sale.
Schedule 13D vs. 13G explained: who files and when
Schedule 13D vs 13G explained: the five percent trigger, who may use the short-form 13G, filing deadlines, amendments, groups and how to read a 13D filing.